New South Wales
Oral Wellness Brand | Built to Scale
For Sale | Refer to Broker
Structured investment opportunity into an Australian oral wellness brand with established pharmacy distribution, proven demand and a scalable operating model.
Key highlights:
• Distribution across 80+ pharmacy and health retail locations, including Priceline, TerryWhite and independent operators
• Established Chemist Warehouse online presence, driving validation and revenue
• ~80%-86% gross margins with ~50% contribution margins
• ~5% month-on-month growth achieved over ~30 months
• Early-stage direct-to-consumer channel providing customer data and margin visibility
• Operating at or near breakeven with a disciplined cost base
The business operates within the emerging oral wellness category, aligned with broader trends in preventative health, microbiome awareness and daily functional care. Over ~30 months, the model has been built without external capital, focusing on product validation, controlled distribution growth and consistent unit economics.
The opportunity is a part-share investment into a validated platform, now positioned at an inflection point between validation and scale. Growth is expected to be driven through expanded pharmacy distribution, increased brand awareness and the scaling of digital customer acquisition and retention channels.
This opportunity will suit investors or strategic operators with experience in FMCG, health or retail distribution who can support execution at scale. It is an execution-led growth opportunity rather than a passive investment.
Contact
Business Broker: Theo Pettaras
Ref: NSW12180
Mobile: 0405 102 102
Email: theo.pettaras@linkbusiness.com.au
Ref: NSW12180
Timestamp: 20260424033003
Key highlights:
• Distribution across 80+ pharmacy and health retail locations, including Priceline, TerryWhite and independent operators
• Established Chemist Warehouse online presence, driving validation and revenue
• ~80%-86% gross margins with ~50% contribution margins
• ~5% month-on-month growth achieved over ~30 months
• Early-stage direct-to-consumer channel providing customer data and margin visibility
• Operating at or near breakeven with a disciplined cost base
The business operates within the emerging oral wellness category, aligned with broader trends in preventative health, microbiome awareness and daily functional care. Over ~30 months, the model has been built without external capital, focusing on product validation, controlled distribution growth and consistent unit economics.
The opportunity is a part-share investment into a validated platform, now positioned at an inflection point between validation and scale. Growth is expected to be driven through expanded pharmacy distribution, increased brand awareness and the scaling of digital customer acquisition and retention channels.
This opportunity will suit investors or strategic operators with experience in FMCG, health or retail distribution who can support execution at scale. It is an execution-led growth opportunity rather than a passive investment.
Contact
Business Broker: Theo Pettaras
Ref: NSW12180
Mobile: 0405 102 102
Email: theo.pettaras@linkbusiness.com.au
Ref: NSW12180
Timestamp: 20260424033003
